TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/01/2025
Voltar para busca
Dado oficial do USPTO
RENALYTIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RENALYTIX
ST13
US500000088956751Classe
10, 42, 44
Pedido
88956751
Registro
7170059
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
18/01/2025
Tipo de marca
Verbal
Classes Nice
10, 42, 44
Data de depósito
09/06/2020
Data de registro
19/09/2023
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/09/2023
Última transação
18/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
09/06/2021
Primeiro uso no comércio
09/06/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
New York, NY, US
Examinador
CORNWELL, ANDREA B
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Renalytix AI, Inc.
Representantes
John Maldjian Stevens & Lee, P.C.
Classificação técnica
Classes Nice
Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Blood test collection kit comprised of blood collection bagholder for medical sample tubesvialstest tripsmedical sample tubesvialstest strips for predictingidentifying and determining the presence and stage of kidney diseases
Classe 42
Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; researchdevelopment and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney diseases; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis
Classe 44
Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/01/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/01/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
19/09/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16/08/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2023
ALIE
ASSIGNED TO LIE
04/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/01/2023
GNRT
NON-FINAL ACTION E-MAILED
24/01/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
24/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/01/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/01/2023
EX4G
SOU EXTENSION 4 GRANTED
05/01/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/01/2023
IUAF
USE AMENDMENT FILED
15/12/2022
EXT4
SOU EXTENSION 4 FILED
15/12/2022
EEXT
SOU TEAS EXTENSION RECEIVED
15/12/2022
EISU
TEAS STATEMENT OF USE RECEIVED
15/12/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/06/2022
EX3G
SOU EXTENSION 3 GRANTED
14/06/2022
EXT3
SOU EXTENSION 3 FILED
14/06/2022
EEXT
SOU TEAS EXTENSION RECEIVED
14/06/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/12/2021
EX2G
SOU EXTENSION 2 GRANTED
14/12/2021
EXT2
SOU EXTENSION 2 FILED
14/12/2021
EEXT
SOU TEAS EXTENSION RECEIVED
14/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/11/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/11/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/11/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/06/2021
EX1G
SOU EXTENSION 1 GRANTED
14/06/2021
EXT1
SOU EXTENSION 1 FILED
14/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
14/06/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/10/2020
PUBO
PUBLISHED FOR OPPOSITION
20/10/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
15/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
15/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/09/2020
DOCK
ASSIGNED TO EXAMINER
11/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2020
NWAP
NEW APPLICATION ENTERED
12/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RENALYTIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.